Related Experiment Video
Updated: Feb 25, 2026

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
Published on: June 14, 2016
Spontaneous myocardial injury in hypertrophic cardiomyopathy: Coexistence of microvascular dysfunction and
Maethas Panyawongkhanti1,2, Nonthikorn Theerasuwipakorn1,3, Apichai Khongphatthanayothin4,5
1Division of Cardiovascular Medicine, Department of Medicine, Faculty of Medicine, Chulalongkorn University, King Chulalongkorn Memorial Hospital, Bangkok 10330, Thailand.
Insights
This case study shows microvascular obstruction (MVO) can occur with microvascular dysfunction (MVD) in hypertrophic cardiomyopathy (HCM). This highlights a complex interplay potentially worsening myocardial injury and disease progression in HCM patients.
Area of Science:
- Cardiology
- Genetics
- Medical Imaging
Background:
- Hypertrophic cardiomyopathy (HCM) is a genetic heart muscle disease.
- Microvascular dysfunction (MVD) is a common complication leading to myocardial ischemia.
- Microvascular obstruction (MVO) in HCM is rarely reported.
Abstract:
Hypertrophic cardiomyopathy (HCM) is a genetic disorder characterized by left ventricular hypertrophy without abnormal loading conditions, often complicated by microvascular dysfunction (MVD), which leads to myocardial ischemia. While MVD in HCM has been extensively described, reports of concomitant microvascular obstruction (MVO) as a feature of spontaneous myocardial injury are scarce. We present a 58-year-old man with genetically confirmed HCM who experienced recurrent chest discomfort attributed to spontaneous myocardial injury. This was evidenced by markedly elevated biomarkers and cardiac magnetic resonance imaging (CMR) findings, including severe inducible myocardial ischemia on stress perfusion, myocardial edema, and MVO. This case highlights the potential coexistence of MVD and MVO in severe HCM, suggesting a complex interplay that may contribute to disease progression. Advanced imaging techniques, particularly CMR, are crucial in detecting myocardial damage and guiding management. Future research should explore the clinical significance of MVO in HCM and its potential as a therapeutic target.
More Related Videos
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Myocarditis I: Introduction
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy II: Dilated Cardiomyopathy
Coronary Artery Disease II: Pathophysiology
Cardiomyopathy V: Interprofessional Care

